Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L M Aledort

Showing results (1-10 of 187) with videos related to

Pageof 19
Sort By:
The New England Journal of Medicine|October 6, 2001
HemophiliaL M Aledort
Haemophilia : the Official Journal of the World Federation of Hemophilia|March 10, 2001
Making a therapeutic choice: human versus recombinant fractions - can we do it?L M Aledort
Haemophilia : the Official Journal of the World Federation of Hemophilia|February 24, 2001
Unexpected bleeding disorders: identification, diagnosis and managementL M Aledort
Journal of Thrombosis and Haemostasis : JTH|December 15, 2010
Harmonization of clinical trial guidelines for assessing the risk of inhibitor development in hemophilia A treatmentL M Aledort
Thrombosis and Haemostasis|March 15, 2001
Rebuttal to massive skin necrosis associated to the prothrombin gene G20210A mutationL M Aledort
Haemophilia : the Official Journal of the World Federation of Hemophilia|April 16, 2014
The effect of a specialized case management programme on the cost of factor replacement use in patients with bleeding disordersL M Aledort
Journal of Thrombosis and Haemostasis : JTH|March 11, 2004
AIDS, hepatitis and hemophiliaL M Aledort
Hospital Practice (Office Ed.)|September 1, 1983
AIDS: an updateL M Aledort
Seminars in Hematology|April 1, 1988
Blood products and immune changes: impacts without HIV infectionL M Aledort
Hospital Practice|July 1, 1979
At last--a national blood policy?L M Aledort
Pageof 19

Showing results (1-10 of 187) with videos related to

Sort By:
Pageof 19
The New England Journal of Medicine|October 6, 2001
HemophiliaL M Aledort
Haemophilia : the Official Journal of the World Federation of Hemophilia|March 10, 2001
Making a therapeutic choice: human versus recombinant fractions - can we do it?L M Aledort
Haemophilia : the Official Journal of the World Federation of Hemophilia|February 24, 2001
Unexpected bleeding disorders: identification, diagnosis and managementL M Aledort
Journal of Thrombosis and Haemostasis : JTH|December 15, 2010
Harmonization of clinical trial guidelines for assessing the risk of inhibitor development in hemophilia A treatmentL M Aledort
Thrombosis and Haemostasis|March 15, 2001
Rebuttal to massive skin necrosis associated to the prothrombin gene G20210A mutationL M Aledort
Haemophilia : the Official Journal of the World Federation of Hemophilia|April 16, 2014
The effect of a specialized case management programme on the cost of factor replacement use in patients with bleeding disordersL M Aledort
Journal of Thrombosis and Haemostasis : JTH|March 11, 2004
AIDS, hepatitis and hemophiliaL M Aledort
Hospital Practice (Office Ed.)|September 1, 1983
AIDS: an updateL M Aledort
Seminars in Hematology|April 1, 1988
Blood products and immune changes: impacts without HIV infectionL M Aledort
Hospital Practice|July 1, 1979
At last--a national blood policy?L M Aledort
Pageof 19